NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.
Yun
Oliver
O
Médecins Sans Frontières/Doctors Without Borders, New York, New York, USA. oliver.yun@newyork.msf.org
Priotto
Gerardo
G
Tong
Jacqueline
J
Flevaud
Laurence
L
Chappuis
François
F
D017954:Africa South of the Sahara / Q000453:epidemiology; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000009:adverse effects / Q000627:therapeutic use*; D019353:Endemic Diseases; D006801:Humans; D009547:Nifurtimox / Q000009:adverse effects / Q000627:therapeutic use*; D014347:Trypanosoma brucei gambiense / Q000187:drug effects*; D014353:Trypanosomiasis, African / Q000188:drug therapy* / Q000453:epidemiology*
D000981:Antiprotozoal Agents; D009547:Nifurtimox; D000518:Eflornithine